HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven J Chmura Selected Research

Steven J Chmura Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 02/2003
22Neoplasm Metastasis (Metastasis)
01/2022 - 02/2006
11Breast Neoplasms (Breast Cancer)
12/2020 - 02/2005
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 06/2010
4Head and Neck Neoplasms (Head and Neck Cancer)
05/2006 - 02/2003
3Brain Neoplasms (Brain Tumor)
01/2020 - 01/2014
3Glioblastoma (Glioblastoma Multiforme)
01/2020 - 03/2012
3Anus Neoplasms (Anal Cancer)
11/2009 - 10/2005
2Pneumonia (Pneumonitis)
11/2022 - 01/2022
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2007 - 10/2005
1Disease Progression
01/2022
1Glioma (Gliomas)
12/2021
1Anetoderma
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Bites and Stings (Sting)
01/2021
1Infections
07/2020
1COVID-19
07/2020
1Gliosarcoma
01/2020
1Fatigue
01/2020
1Neurobehavioral Manifestations
01/2020
1Neurologic Manifestations (Neurological Manifestations)
01/2020
1Mediastinal Diseases
01/2019
1Merkel Cell Carcinoma
01/2019
1Astrocytoma (Pilocytic Astrocytoma)
09/2018
1Multiple Myeloma
11/2017
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2017
1Lung Neoplasms (Lung Cancer)
01/2017
1AIDS-Related Complex (ARC)
01/2017
1Necrosis
04/2014
1Pituitary Neoplasms (Pituitary Adenoma)
09/2006
1Squamous Cell Carcinoma of Head and Neck
02/2006
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2004
1Primitive Neuroectodermal Tumors (PNET)
06/2004
1Cholangiocarcinoma
06/2004

Drug/Important Bio-Agent (IBA)

5pembrolizumabIBA
01/2022 - 01/2018
5Immune Checkpoint InhibitorsIBA
10/2021 - 01/2018
4Biological ProductsIBA
01/2019 - 01/2011
4MicroRNAs (MicroRNA)IBA
06/2016 - 01/2011
3Temozolomide (Temodar)FDA LinkGeneric
12/2021 - 03/2012
3Bevacizumab (Avastin)FDA Link
12/2021 - 04/2014
2NivolumabIBA
01/2022 - 10/2021
2InterferonsIBA
01/2021 - 01/2018
2B7-H1 AntigenIBA
01/2021 - 01/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 04/2014
2Contrast MediaIBA
10/2010 - 08/2010
2Deoxyglucose (2 Deoxy D glucose)IBA
10/2010 - 08/2010
2GoldIBA
10/2010 - 08/2010
1IpilimumabIBA
01/2022
1urelumabIBA
10/2021
1cabiralizumabIBA
10/2021
1Butyrates (Butyrate)IBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1trebananibIBA
01/2020
1Memantine (Namenda)FDA Link
01/2020
1Interferon-gamma (Interferon, gamma)IBA
01/2019
1LigandsIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Blocking AntibodiesIBA
01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Neoplasm Antigens (Tumor Antigens)IBA
01/2018
1CytokinesIBA
01/2018
1SilverIBA
05/2017
1veliparibIBA
01/2016
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2016
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2016
1Monoclonal AntibodiesIBA
04/2014
1bistratene AIBA
06/2010
1Actins (F Actin)IBA
06/2010
1phytobacteriomycin (PBM)IBA
04/2008
1IfosfamideFDA LinkGeneric
06/2004
1Etoposide (VP 16)FDA LinkGeneric
06/2004

Therapy/Procedure

35Radiotherapy
11/2022 - 10/2005
25Therapeutics
01/2022 - 12/2004
9Drug Therapy (Chemotherapy)
01/2019 - 12/2004
5Immunotherapy
11/2022 - 01/2019
4Re-Irradiation
12/2021 - 02/2003
4Segmental Mastectomy (Lumpectomy)
01/2017 - 02/2005
2Image-Guided Radiotherapy
10/2013 - 02/2012
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2008 - 06/2004
1Drug Tapering
01/2022
1Salvage Therapy
12/2021
1Particle Accelerators
03/2021
1Radioimmunotherapy
01/2021
1Conformal Radiotherapy
12/2020
1Aftercare (After-Treatment)
11/2018
1Craniospinal Irradiation
11/2017
1Proton Therapy
11/2017
1Animal Assisted Therapy
12/2012
1Chemoradiotherapy
04/2008
1Overlapping Surgery
02/2006
1Mastectomy (Mammectomy)
02/2005